QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Collins, J. J. Articles by Strother, D. E. Search for Related Content PubMed PubMed Citation

CNS tumors and exposure to acrylonitrile: Inconsistency between experimental and epidemiology studies

Solutia, Inc., St. Louis, MO 63166-6760 [J.J.C.]; and BP Chemicals, Inc., Warrensville Heights, OH 44128-2837 [D.E.S.]

¹ Address correspondence and reprint requests to James J. Collins, Solutia, Inc., 10300 Olive Boulevard, St. Louis, MO 63166-6760.

Abstract

Acrylonitrile is a potent CNS tumorigen in rats leading to concern that it may be a tumorigen in humans. There have been 12 epidemiology studies of 37,352 workers exposed to acrylonitrile which evaluate CNS cancers. We summarize and evaluate these epidemiology studies for CNS cancers using the methods of meta-analysis. Our analyses indicate that workers with acrylonitrile exposure have null findings for CNS cancer (relative risk = 1.1, 95% confidence interval 0.8-1.5), which are in stark contrast to the projected risk to humans using the rat findings (relative risk = 3.5, 95% confidence interval 3.0-4.0). We discuss several explanations for the inconsistency between animal and human findings, including the possibility that the acrylonitrile-induced rat CNS tumors may not be relevant to humans. Given the rarity of CNS tumors in humans and a lack of understanding of the causal mechanisms of these tumors in rats, however, a more definitive conclusion will have to await additional experimental and observational data. Nevertheless, the epidemiology evidence indicates that acrylonitrile is not a potent CNS tumorigen.

This article has been cited by other articles:

				S. M. Rappaport, L. L. Kupper, and Y. S. Lin On the Importance of Exposure Variability to the Doses of Volatile Organic Compounds Toxicol. Sci., February 1, 2005; 83(2): 224 - 236. [Abstract] [Full Text] [PDF]

				L. M. Sweeney, M. L. Gargas, D. E. Strother, and G. L. Kedderis Physiologically Based Pharmacokinetic Model Parameter Estimation and Sensitivity and Variability Analyses for Acrylonitrile Disposition in Humans Toxicol. Sci., January 1, 2003; 71(1): 27 - 40. [Abstract] [Full Text] [PDF]